[(177)Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.
来源：PubMed发布日期：2026-06-01作者：Baudin E, Durand A, Beron A, Smith D, Déandreis D0 次点击